These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28392208)

  • 1. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
    Boggs DL; Surti TS; Esterlis I; Pittman B; Cosgrove K; Sewell RA; Ranganathan M; D'Souza DC
    Schizophr Res; 2018 Apr; 194():62-69. PubMed ID: 28392208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
    Evins AE; Deckersbach T; Cather C; Freudenreich O; Culhane MA; Henderson DC; Green MF; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychiatry; 2005 Sep; 66(9):1184-90. PubMed ID: 16187778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.
    Cather C; Hoeppner S; Pachas G; Pratt S; Achtyes E; Cieslak KM; Evins AE
    J Dual Diagn; 2017; 13(3):168-178. PubMed ID: 28414583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.
    Moss TG; Sacco KA; Allen TM; Weinberger AH; Vessicchio JC; George TP
    Drug Alcohol Depend; 2009 Sep; 104(1-2):94-9. PubMed ID: 19447570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.
    Hahn B; Harvey AN; Concheiro-Guisan M; Huestis MA; Holcomb HH; Gold JM
    Biol Psychiatry; 2013 Sep; 74(6):436-43. PubMed ID: 23660272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Smith RC; Lindenmayer JP; Davis JM; Cornwell J; Noth K; Gupta S; Sershen H; Lajtha A
    Schizophr Res; 2009 May; 110(1-3):149-55. PubMed ID: 19251401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
    Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP
    Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Tobacco Smoking Status on Verbal Learning and Memory in Patients With Schizophrenia and Non-Psychiatric Controls.
    Kozak K; Lowe DJE; George TP
    Am J Addict; 2019 Nov; 28(6):503-511. PubMed ID: 31291035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of smoking abstinence on visuospatial working memory function in schizophrenia.
    George TP; Vessicchio JC; Termine A; Sahady DM; Head CA; Pepper WT; Kosten TR; Wexler BE
    Neuropsychopharmacology; 2002 Jan; 26(1):75-85. PubMed ID: 11751034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.
    AhnAllen CG; Bidwell LC; Tidey JW
    Nicotine Tob Res; 2015 May; 17(5):510-4. PubMed ID: 25143294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Dickerson F; Adamos MB; Katsafanas E; Khushalani S; Origoni A; Savage CLG; Schroeder J; Schweinfurth LAB; Stallings C; Sweeney K; Yolken R
    Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers.
    Jacobsen LK; Krystal JH; Mencl WE; Westerveld M; Frost SJ; Pugh KR
    Biol Psychiatry; 2005 Jan; 57(1):56-66. PubMed ID: 15607301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco and cognitive performance in schizophrenia patients: the design of the COGNICO study.
    Al-Halabí S; Fernández-Artamendi S; Díaz-Mesa EM; García-Álvarez L; Flórez G; Martínez-Santamaría E; Arrojo M; Saiz PA; García-Portilla MP; Bobes J
    Adicciones; 2016 Jun; 29(1):6-12. PubMed ID: 27391843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive functions in smoking and non-smoking patients with schizophrenia: A systematic review and meta-analysis of comparative studies.
    Wang YY; Wang S; Zheng W; Zhong BL; Ng CH; Ungvari GS; Wang CX; Xiang YT; Li XH
    Psychiatry Res; 2019 Feb; 272():155-163. PubMed ID: 30583258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicotine nasal spray on cognitive function in schizophrenia.
    Smith RC; Warner-Cohen J; Matute M; Butler E; Kelly E; Vaidhyanathaswamy S; Khan A
    Neuropsychopharmacology; 2006 Mar; 31(3):637-43. PubMed ID: 16160711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.